Iron overload in thalassemia and sickle cell disease

Seminars in Hematology

Volumn 42, Issue 2 SUPPL. 1, 2005, Pages S5-

  Taher, A ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; DEFERIPRONE; DEFEROXAMINE;

ALPHA THALASSEMIA; BETA GLOBIN GENE; BETA THALASSEMIA; BONE MARROW TRANSPLANTATION; CELL MATURATION; CHELATION THERAPY; CONFERENCE PAPER; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG TOLERANCE; ERYTHROCYTE; ERYTHROPOIESIS; GENE; GENE MUTATION; GENE SILENCING; GENE THERAPY; GENETIC DISORDER; HEMOGLOBIN DETERMINATION; HUMAN; IRON CHELATION; IRON METABOLISM; IRON OVERLOAD; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STATISTICAL SIGNIFICANCE;

EID: 15744372350     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2005.01.005     Document Type: Conference Paper

References (43)

1. A. Aessopos, G. Stamatelos, V. Skoumas Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia Chest 107 1995 50 53
2. V.R. Arruda, C.S. Lima, S.T. Saad Successful use of hydroxyurea in beta-thalassemia major N Engl J Med 336 1997 964 965
3. M. Barry, D.M. Flynn, E.A. Letsky Long-term chelation therapy in thalassaemia major Effect on liver iron concentration, liver histology, and clinical progress Br Med J 2 1974 16 20
4. M. Bradai, M.T. Abad, S. Pissard Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia Blood 102 2003 1529 1530
5. C. Brugnara, L. De Franceschi, Y. Beuzard Erythrocyte-active agents and treatment of sickle cell disease Semin Hematol 38 2001 324 332
6. C. Camaschella, M.D. Cappellini Thalassemia intermedia Haematologica 80 1995 58 68
7. M.D. Cappellini, G. Graziadei, L. Ciceri Oral isobutyramide therapy in patients with thalassemia intermedia Results of a phase II open study Blood Cells Mol Dis 26 2000 105 111
8. M. Cazzola, C. Borgna-Pignatti, F. Locatelli A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis Transfusion 37 1997 135 140
9. J.D. Cook, G. Marsaglia, J.W. Eschbach Ferrokinetics A biologic model for plasma iron exchange in man J Clin Invest 49 1970 197 205
10. L. De Franceschi, R. Corroche Established and experimental treatments for sickle cell disease Haematologica 89 2004 348 356
11. V. De Sanctis Growth and puberty and its management in thalassaemia Horm Res 58 suppl 1 2002 72 79
12. K.H. Ehlers, P.J. Giardina, M.L. Lesser Prolonged survival in patients with beta-thalassemia major treated with deferoxamine J Pediatr 118 1991 540 545
13. L. Gullo, E. Corcioni, C. Brancati Morphologic and functional evaluation of the exocrine pancreas in beta-thalassemia major Pancreas 8 1993 176 180
14. C. Hershko, A.M. Konijn, G. Link Iron chelators for thalassaemia Br J Haematol 101 1998 399 406
15. C. Hershko, E.A. Rachmilewitz Mechanism of desferrioxamine-induced iron excretion in thalassaemia Br J Haematol 42 1979 125 132
16. C. Hershko, D.J. Weatherall Iron-chelating therapy Crit Rev Clin Lab Sci 26 1988 303 345
17. C.E. Jensen, S.M. Tuck, J.E. Agnew High prevalence of low bone mass in thalassaemia major Br J Haematol 103 1998 911 915
18. R. Jiang, J.E. Manson, J.B. Meigs Body iron stores in relation to risk of type 2 diabetes in apparently healthy women JAMA 291 2004 711 717
19. D.T. Kremastinos, G. Tiniakos, G.N. Theodorakis Myocarditis in beta-thalassemia major A cause of heart failure Circulation 91 1995 66 71
20. S.E. Lawson, I.A. Roberts, P. Amrolia Bone marrow transplantation for beta-thalassaemia major The UK experience in two paediatric centres Br J Haematol 120 2003 289 295
21. C.K. Li, K.W. Chik, G.W. Wong Growth and endocrine function following bone marrow transplantation for thalassemia major Pediatr Hematol Oncol 21 2004 411 419
22. L.C. Low Growth, puberty and endocrine function in beta-thalassaemia major J Pediatr Endocrinol Metab 10 1997 175 184
23. R.E. Marcus, S.C. Davies, H.M. Bantock Desferrioxamine to improve cardiac function in iron-overloaded patients with thalassemia major Lancet 1 1984 392 393
24. B. Modell, M. Khan, M. Darlison Survival in beta-thalassaemia major in the UK Data from the UK Thalassaemia Register Lancet 355 2000 2051 2052
25. N. Mohandas, E. Evans Adherence of sickle erythrocytes to vascular endothelial cells Requirement for both cell membrane changes and plasma factors Blood 64 1984 282 287
26. C.R. Morris, E.P. Vichinsky, J. van Warmerdam Hydroxyurea and arginine therapy Impact on nitric oxide production in sickle cell disease J Pediatr Hematol Oncol 25 2003 629 634
27. N. Olivieri Thalassaemia Clinical management Baillieres Clin Haematol 11 1998 147 162
28. N.F. Olivieri Reactivation of fetal hemoglobin in patients with beta-thalassemia Semin Hematol 33 1996 24 42
29. N.F. Olivieri The beta-thalassemias N Engl J Med 341 1999 99 109
30. N.F. Olivieri, G.M. Brittenham Iron-chelating therapy and the treatment of thalassemia Blood 89 1997 739 761
31. N.F. Olivieri, D.C. Rees, G.D. Ginder Treatment of thalassaemia major with phenylbutyrate and hydroxyurea Lancet 350 1997 491 492
32. A. Pathare, S.A. Kindi, S. Daar Cytokines in sickle cell disease Hematology 8 2003 329 337
33. P. Pootrakul, K. Kitcharoen, P. Yansukon The effect of erythroid hyperplasia on iron balance Blood 71 1988 1124 1129
34. Y. Saunthararajah, C.A. Hillery, D. Lavelle Effects of 5-aza-2′-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease Blood 102 2003 3865 3870
35. P. Stal Iron as a hepatotoxin Dig Dis 13 1995 205 222
36. M.H. Steinberg Management of sickle cell disease N Engl J Med 340 1999 1021 1030
37. M.H. Steinberg, F. Barton, O. Castro Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia Risks and benefits up to 9 years of treatment JAMA 289 2003 1645 1651
38. J.L. Wautier, D. Pintigny, M.P. Wautier Fibrinogen, a modulator of erythrocyte adhesion to vascular endothelium J Lab Clin Med 101 1983 911 920
39. D.J. Weatherall, J.B. Clegg Thalassemia--A global public health problem Nat Med 2 1996 847 849
40. N. Westerdale, T. Jegede Managing the problem of pain in adolescents with sickle cell disease Prof Nurse 19 2004 402 405
41. L. Wolfe, N. Olivieri, D. Sallan Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major N Engl J Med 312 1985 1600 1603
42. J.C. Wood, J.M. Tyszka, S. Carson Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease Blood 103 2004 1934 1936
43. M.G. Zurlo, P. De Stefano, C. Borgna-Pignatti Survival and causes of death in thalassaemia major Lancet 2 1989 27 30